During the past decade, Wayne State University Clinical Research Center conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Wayne State University Clinical Research Center" are "Adverse Effect of Other Antipsychotics and Neuroleptics" (1 trials), "Antipsychotic Agents" (1 trials), "Bipolar Disorder" (1 trials) and "Insulin Resistance" (1 trials). Many other conditions were trialed in "Wayne State University Clinical Research Center" in a lesser frequency.

Most popular intervention types in "Wayne State University Clinical Research Center" are "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "olanzapine" (1 trials) and "placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Wayne State University Clinical Research Center" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Wayne State University Clinical Research Center". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Wayne State University Clinical Research Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Wayne State University Clinical Research Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".